Pfizer Inc. stock has November 3 call, slightly higher pre-market
Published on 10/22/2026 at 08:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSPfizer sets analyst webcast
- Pfizer announced the analyst webcast in a September 22, 2026 release.
- The webcast is scheduled for November 3, 2026.
- Pfizer Inc. stock trades pre-market at EUR 26.68 at 8:37 a.m. CEST at Lang & Schwarz on October 22, 2026, 0.53 percent above the Xetra close of October 21, 2026.
Pfizer announced an analyst conference call scheduled for November 3, 2026, in a September 22, 2026, release on its website. Pfizer Inc. stock trades pre-market at EUR 26.68 at 8:37 a.m. CEST at Lang & Schwarz on October 22, 2026, 0.53 percent above the Xetra close of October 21, 2026 (EUR 26.54). The announcement is described in the Pfizer release.
Pfizer's next company date
The November 3 call is listed as an opportunity to listen to Pfizer's discussion with analysts. The company’s website identifies the event in its press-release section and dates the announcement September 22, 2026. The company website also describes Pfizer as a biopharmaceutical company.
Ahead of the Xetra open
The pre-market indication is EUR 0.14 above the Xetra close of October 21, 2026. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Pfizer stock.
Business and today's agenda
Pfizer develops medicines and vaccines for the treatment and prevention of disease. Its next scheduled analyst call is on November 3, 2026, according to the Pfizer website. Market context: Market report S&P 500.
